|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2004-6-1
|
|
pubmed:abstractText |
To determine the effects of treatment on the radiologic manifestations of joint damage in patients with rheumatoid arthritis (RA) who participated in a 24-week extension study of a randomized, placebo-controlled clinical trial of anakinra, a recombinant human interleukin 1 receptor antagonist.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0315-162X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1103-11
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15170922-Adult,
pubmed-meshheading:15170922-Aged,
pubmed-meshheading:15170922-Antirheumatic Agents,
pubmed-meshheading:15170922-Arthritis, Rheumatoid,
pubmed-meshheading:15170922-Female,
pubmed-meshheading:15170922-Humans,
pubmed-meshheading:15170922-Interleukin 1 Receptor Antagonist Protein,
pubmed-meshheading:15170922-Joints,
pubmed-meshheading:15170922-Male,
pubmed-meshheading:15170922-Middle Aged,
pubmed-meshheading:15170922-Severity of Illness Index,
pubmed-meshheading:15170922-Sialoglycoproteins,
pubmed-meshheading:15170922-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Effects of anakinra monotherapy on joint damage in patients with rheumatoid arthritis. Extension of a 24-week randomized, placebo-controlled trial.
|
|
pubmed:affiliation |
Department of Rheumatology, St. Vincents University Hospital, Dublin, Ireland. b.bresnihan@svcpc.ie
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
